Literature DB >> 8396137

A requirement for Ras protein function in thrombin-stimulated mitogenesis in astrocytoma cells.

V J LaMorte1, E D Kennedy, L R Collins, D Goldstein, A T Harootunian, J H Brown, J R Feramisco.   

Abstract

Thrombin stimulation of 1321N1 astrocytoma cells results in polyphosphoinositide hydrolysis, Ca2+ mobilization, AP-1-mediated transcriptional activation, and DNA replication. Thrombin stimulation also activates Ras as assessed by an increase in the proportion of Ras in a GTP bound state. We examined the functional requirement for endogenous Ras protein in mediating thrombin-induced responses. Microinjection of a dominant interfering mutant of H-Ras into 1321N1 cells inhibited DNA synthesis in response to thrombin as did microinjection of an inhibitory antibody to Ras. Stimulation of AP-1-mediated transcriptional activity was also reduced by the expression of interfering Ras mutants. However, neither the stimulation of polyphosphoinositide hydrolysis nor the mobilization of intracellular Ca2+ was dependent on endogenous Ras function. These observations indicate that thrombin stimulation of mitogenesis requires Ras protein function. Our data suggest that the G-protein-coupled thrombin receptor stimulates pathways, which in part are convergent with those stimulated by tyrosine kinase growth factor receptors.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8396137

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

1.  Thrombin inhibits Bim (Bcl-2-interacting mediator of cell death) expression and prevents serum-withdrawal-induced apoptosis via protease-activated receptor 1.

Authors:  Claire J Chalmers; Kathryn Balmanno; Kathryn Hadfield; Rebecca Ley; Simon J Cook
Journal:  Biochem J       Date:  2003-10-01       Impact factor: 3.857

2.  Coupling of the thrombin receptor to G12 may account for selective effects of thrombin on gene expression and DNA synthesis in 1321N1 astrocytoma cells.

Authors:  G R Post; L R Collins; E D Kennedy; S A Moskowitz; A M Aragay; D Goldstein; J H Brown
Journal:  Mol Biol Cell       Date:  1996-11       Impact factor: 4.138

Review 3.  Proteinases and signalling: pathophysiological and therapeutic implications via PARs and more.

Authors:  R Ramachandran; M D Hollenberg
Journal:  Br J Pharmacol       Date:  2007-12-03       Impact factor: 8.739

4.  Ras activation in platelets after stimulation of the thrombin receptor, thromboxane A2 receptor or protein kinase C.

Authors:  D D Shock; K He; J D Wencel-Drake; L V Parise
Journal:  Biochem J       Date:  1997-01-15       Impact factor: 3.857

5.  Cytosolic phospholipase A2 is coupled to muscarinic receptors in the human astrocytoma cell line 1321N1: characterization of the transducing mechanism.

Authors:  Y Bayon; M Hernandez; A Alonso; L Nuñez; J Garcia-Sancho; C Leslie; M Sanchez Crespo; M L Nieto
Journal:  Biochem J       Date:  1997-04-01       Impact factor: 3.857

6.  Shc adaptor proteins are key transducers of mitogenic signaling mediated by the G protein-coupled thrombin receptor.

Authors:  Y Chen; D Grall; A E Salcini; P G Pelicci; J Pouysségur; E Van Obberghen-Schilling
Journal:  EMBO J       Date:  1996-03-01       Impact factor: 11.598

Review 7.  Cellular consequences of thrombin-receptor activation.

Authors:  R J Grand; A S Turnell; P W Grabham
Journal:  Biochem J       Date:  1996-01-15       Impact factor: 3.857

8.  Expression cloning of oncogenes by retroviral transfer of cDNA libraries.

Authors:  I Whitehead; H Kirk; R Kay
Journal:  Mol Cell Biol       Date:  1995-02       Impact factor: 4.272

9.  Muscarinic receptors transform NIH 3T3 cells through a Ras-dependent signalling pathway inhibited by the Ras-GTPase-activating protein SH3 domain.

Authors:  R R Mattingly; A Sorisky; M R Brann; I G Macara
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

Review 10.  Regulation of Bim in Health and Disease.

Authors:  Ronit Vogt Sionov; Spiros A Vlahopoulos; Zvi Granot
Journal:  Oncotarget       Date:  2015-09-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.